Stockscreener 앱 받기
16.15
0.31%
0.05
시간 외 거래:
15.91
-0.24
-1.49%
전일 마감가:
$16.10
열려 있는:
$16.17
하루 거래량:
2.41M
Relative Volume:
0.87
시가총액:
$3.82B
수익:
$382.81M
순이익/손실:
$68.13M
주가수익비율:
57.68
EPS:
0.28
순현금흐름:
$78.82M
1주 성능:
+0.44%
1개월 성능:
-5.83%
6개월 성능:
+31.51%
1년 성능:
+211.18%
1일 변동 폭
$15.86
$16.39
1주일 범위
$15.48
$16.60
52주 변동 폭
$5.02
$23.64
Adma Biologics Inc Stock (ADMA) Company Profile
명칭
Adma Biologics Inc
전화
(201) 478-5552
주소
C/O ADMA BIOLOGICS, INC., RAMSEY
ADMA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ADMA
Adma Biologics Inc
|
16.15 | 3.82B | 382.81M | 68.13M | 78.82M | 0.28 |
|
VRTX
Vertex Pharmaceuticals Inc
|
461.68 | 118.90B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
672.98 | 73.95B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
655.13 | 39.81B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
271.31 | 34.99B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
123.77 | 29.67B | 3.30B | -501.07M | 1.03B | -2.1146 |
Adma Biologics Inc Stock (ADMA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2023-07-19 | 재개 | Raymond James | Strong Buy |
| 2022-10-13 | 개시 | Mizuho | Buy |
| 2021-11-11 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2021-11-09 | 개시 | Cantor Fitzgerald | Overweight |
| 2019-06-04 | 개시 | Jefferies | Buy |
| 2019-04-15 | 재확인 | H.C. Wainwright | Buy |
| 2019-02-07 | 재개 | H.C. Wainwright | Buy |
| 2017-12-11 | 재확인 | Maxim Group | Buy |
| 2017-11-14 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2017-01-23 | 업그레이드 | Maxim Group | Hold → Buy |
| 2016-08-01 | 다운그레이드 | Maxim Group | Buy → Hold |
| 2016-07-25 | 재확인 | Maxim Group | Buy |
| 2015-05-13 | 재확인 | Maxim Group | Buy |
| 2014-12-08 | 개시 | Oppenheimer | Outperform |
| 2014-12-01 | 재확인 | Maxim Group | Buy |
모두보기
Adma Biologics Inc 주식(ADMA)의 최신 뉴스
ADMA Biologics, Inc. (NASDAQ:ADMA) Short Interest Up 11.8% in January - MarketBeat
Jim Cramer on ADMA Biologics, Inc. (ADMA): ‘I Would Wait For It To Come Down Before I Would Pull The Trigger’ - Insider Monkey
8 Stocks on Jim Cramer’s Radar - Insider Monkey
Jim Cramer Likes This Tech Stock: 'Terrific Business, Niche Business' - Benzinga
Where are the Opportunities in (ADMA) - Stock Traders Daily
Adma Biologics (ADMA) Stock Declines While Market Improves: Some Information for Investors - Yahoo Finance
ADMA Biologics, Inc. (NASDAQ:ADMA) Shares Sold by Inspire Investing LLC - MarketBeat
Veracity Capital LLC Boosts Holdings in ADMA Biologics, Inc. (NASDAQ:ADMA) - MarketBeat
ADMA Biologics to acquire certain assets from Biotest Pharmaceuticals Corp - Reuters
Adma Biologics (ADMA) Rises Higher Than Market: Key Facts - Yahoo Finance
Peering Into ADMA Biologics's Recent Short Interest - Benzinga
Brokers Set Expectations for ADMA Biologics FY2025 Earnings - MarketBeat
Perpetual Ltd Acquires Shares of 3,632,677 ADMA Biologics, Inc. (NASDAQ:ADMA) - MarketBeat
ADMA Stock Catapults 275.7% in a Year: How Should You Play the Stock? - MSN
Blood Plasma Market Growing at 4.07% CAGR to Hit 42.0 Billion USD by 2032 | Emergent BioSolutions, ADMA - EIN News
There May Still Be Time to Get in on These 3 Trending Biotechs - MarketBeat
Sana Biotechnology Inc (SANA-Q) QuotePress Release - The Globe and Mail
How the (ADMA) price action is used to our Advantage - Stock Traders Daily
Assenagon Asset Management S.A. Sells 2,882,776 Shares of ADMA Biologics, Inc. (NASDAQ:ADMA) - Defense World
ADMA Biologics Inc. (ADMA): Why Should You Buy This Growth Stock For The Next 5 Years? - Insider Monkey
ADMA Biologics, Inc. (NASDAQ:ADMA) Short Interest Update - MarketBeat
ADMA Biologics, Inc. (NASDAQ:ADMA) Shares Sold by JPMorgan Chase & Co. - MarketBeat
Brokers Issue Forecasts for ADMA Biologics FY2024 Earnings - Defense World
Adma Biologics (ADMA) Stock Sinks As Market Gains: Here's Why - MSN
ADMA Biologics (NASDAQ:ADMA) Stock Price Down 8.8%Here's What Happened - MarketBeat
Analysts Issue Forecasts for ADMA Biologics FY2024 Earnings - MarketBeat
GAMMA Investing LLC Buys 967 Shares of ADMA Biologics, Inc. (NASDAQ:ADMA) - Defense World
ADMA Biologics (NASDAQ:ADMA) Trading Down 8.8%What's Next? - MarketBeat
EWG Elevate Inc. Invests $480,000 in ADMA Biologics, Inc. (NASDAQ:ADMA) - MarketBeat
ADMA Biologics Announces Preliminary Full Year 2024 Revenue and Provides Business Update - The Manila Times
Adma Biologics (ADMA) Surpasses Market Returns: Some Facts Worth Knowing - MSN
12 Best Growth Stocks Under $25 to Buy Now - Insider Monkey
Is ADMA Biologics, Inc. (ADMA) the Best Growth Stock to Buy Now Under $25? - Insider Monkey
(ADMA) Pivots Trading Plans and Risk Controls - Stock Traders Daily
Is It Worth Investing in Adma Biologics (ADMA) Based on Wall Street's Bullish Views? - MSN
High Growth Tech Stocks to Watch in January 2025 - Yahoo Finance
ADMA Biologics to Participate in the J.P. Morgan Healthcare Conference on January 13, 2025 - The Manila Times
ADMA Biologics, Inc. Appoints Eduardo Rene Salas to Serve on the Board as a Class I Director - Marketscreener.com
Why Is ADMA Biologics, Inc. (ADMA) Among the Best Multibagger Stocks to Buy Right Now? - Insider Monkey
Does ADMA Biologics (NASDAQ:ADMA) Have A Healthy Balance Sheet? - Simply Wall St
12 Best Multibagger Stocks to Buy Right Now - Insider Monkey
Are Medical Stocks Lagging Alvotech (ALVO) This Year? - Yahoo Finance
Adma Biologics Inc (ADMA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
3.95%
2.39%
자본화:
|
볼륨(24시간):